1. Home
  2. FTEK vs XLO Comparison

FTEK vs XLO Comparison

Compare FTEK & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fuel Tech Inc.

FTEK

Fuel Tech Inc.

HOLD

Current Price

$1.71

Market Cap

98.7M

Sector

Industrials

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEK
XLO
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.7M
41.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FTEK
XLO
Price
$1.71
$0.68
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$4.00
$2.00
AVG Volume (30 Days)
168.2K
527.5K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,713,000.00
$31,804,000.00
Revenue This Year
$9.16
$626.78
Revenue Next Year
$21.36
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
588.40
52 Week Low
$0.87
$0.62
52 Week High
$3.65
$1.70

Technical Indicators

Market Signals
Indicator
FTEK
XLO
Relative Strength Index (RSI) 49.11 46.43
Support Level $1.41 $0.63
Resistance Level $1.72 $0.68
Average True Range (ATR) 0.13 0.03
MACD 0.02 0.00
Stochastic Oscillator 75.24 48.69

Price Performance

Historical Comparison
FTEK
XLO

About FTEK Fuel Tech Inc.

Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: